Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain.

Thibodeaux BA, Garbino NC, Liss NM, Piper J, Blair CD, Roehrig JT.

Vaccine. 2012 May 2;30(21):3180-7. doi: 10.1016/j.vaccine.2012.03.003. Epub 2012 Mar 13.

2.

Treatment of yellow fever.

Monath TP.

Antiviral Res. 2008 Apr;78(1):116-24. Epub 2007 Nov 20. Review.

PMID:
18061688
3.

Yellow fever: the recurring plague.

Tomori O.

Crit Rev Clin Lab Sci. 2004;41(4):391-427. Review.

PMID:
15487593
4.

Review of the risks and benefits of yellow fever vaccination including some new analyses.

Monath TP.

Expert Rev Vaccines. 2012 Apr;11(4):427-48. doi: 10.1586/erv.12.6. Review.

PMID:
22551029
5.

[Yellow fever].

Wiercińska-Drapało A.

Przegl Epidemiol. 2004;58 Suppl 1:101-5. Review. Polish.

PMID:
15807166
6.

Experimental therapies for yellow fever.

Julander JG.

Antiviral Res. 2013 Feb;97(2):169-79. doi: 10.1016/j.antiviral.2012.12.002. Epub 2012 Dec 10. Review.

7.

Yellow fever.

Monath TP, Vasconcelos PF.

J Clin Virol. 2015 Mar;64:160-73. doi: 10.1016/j.jcv.2014.08.030. Epub 2014 Oct 24. Review.

PMID:
25453327
8.

Yellow fever: a disease that has yet to be conquered.

Barrett AD, Higgs S.

Annu Rev Entomol. 2007;52:209-29. Review.

PMID:
16913829
9.

The yellow fever 17D vaccine virus: molecular basis of viral attenuation and its use as an expression vector.

Galler R, Freire MS, Jabor AV, Mann GF.

Braz J Med Biol Res. 1997 Feb;30(2):157-68. Review.

PMID:
9239300
10.

T Cell-Mediated Immunity towards Yellow Fever Virus and Useful Animal Models.

Watson AM, Klimstra WB.

Viruses. 2017 Apr 11;9(4). pii: E77. doi: 10.3390/v9040077. Review.

11.

Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy.

Beasley DW, McAuley AJ, Bente DA.

Antiviral Res. 2015 Mar;115:48-70. doi: 10.1016/j.antiviral.2014.12.010. Epub 2014 Dec 26. Review.

PMID:
25545072
12.

Phylogeographic reconstruction of African yellow fever virus isolates indicates recent simultaneous dispersal into east and west Africa.

Beck A, Guzman H, Li L, Ellis B, Tesh RB, Barrett AD.

PLoS Negl Trop Dis. 2013;7(3):e1910. doi: 10.1371/journal.pntd.0001910. Epub 2013 Mar 14. Review.

13.

The epidemiology of yellow fever in Africa.

Mutebi JP, Barrett AD.

Microbes Infect. 2002 Nov;4(14):1459-68. Review.

PMID:
12475636
14.

Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease.

Barrett AD.

Vaccine. 2017 Mar 30. pii: S0264-410X(17)30338-9. doi: 10.1016/j.vaccine.2017.03.032. [Epub ahead of print] Review.

PMID:
28366605
15.

Occurrence of Autoimmune Diseases Related to the Vaccine against Yellow Fever.

Oliveira AC, Maria Henrique da Mota L, Dos Santos-Neto LL, De Carvalho JF, Caldas IR, Martins Filho OA, Tauil PL.

Autoimmune Dis. 2014;2014:473170. doi: 10.1155/2014/473170. Epub 2014 Oct 22. Review.

16.

Animal models for viral haemorrhagic fever.

Falzaran D, Bente DA.

Clin Microbiol Infect. 2015 Jun 22. pii: S1198-743X(15)00537-6. doi: 10.1111/1469-0691.12630. [Epub ahead of print] Review.

PMID:
24690109

Supplemental Content

Support Center